Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. Based in the Netherlands, BlueBee has developed a regulatory compliant, secure cloud platform that simplifies... Read more

Shimadzu Corporation and RIKEN Innovation Co., Ltd. Sign a Collaboration Agreement to Create New Businesses Based on Brain and Five Senses Measurement Research Results from RIKEN

Shimadzu Corporation and RIKEN Innovation Co., Ltd. have signed an agreement to jointly start an R&D program based on measuring the function of the brain and the five senses. The two companies intend to contribute to society by having Shimadzu start new businesses based on research results achieved by RIKEN. RIKEN and Shimadzu Corporation have... Read more

Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI Tech Co., Ltd., Complete Genomics Inc., BGI Americas Corp., and MGI Americas Inc. The preliminary injunction was granted in two patent infringement lawsuits that Illumina... Read more

Global Collaboration Establishes Wales’ National Covid-19 Testing Laboratory

An advanced laboratory dedicated to leading Wales’ national Covid-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies.   Creating a national Covid-19 testing lab at the University Hospital of Wales is an important part of the Welsh Government’s Test, Trace, Protect strategy... Read more

Xylem ranks in Top 20 among 100 Best Corporate Citizens, globally

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 16, 2020– Xylem, a leading global water technology company dedicated to solving the world’s most challenging water issues, has been named one of the 100 Best Corporate Citizens in 3BL Media’s annual ranking of public companies. Xylem ranked 16th in an assessment of 1000 companies globally, rising two places since its... Read more

iSPA Workflow Helps Pharmaceutical Companies Bring New Drugs to Market Faster

Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs HILLSBORO, Ore., June 16, 2020 /PRNewswire/ — To help pharmaceutical companies obtain faster results in their drug discovery process and reduce the cost of bringing new drugs to market, Thermo Fisher Scientific has released the Thermo Scientific iSPA Workflow, the first commercially available single particle analysis (SPA) workflow... Read more

GE Healthcare to collaborate with University of Oxford, NCIMI on AI algorithms to help predict COVID-19 severity, complications and long-term impact

Chalfont St Giles, UK – June 15 2020 GE Healthcare is working with the University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) in the UK to develop and test algorithms to aid in the diagnosis and management of COVID-19 pneumonia. The program will focus on developing, enhancing and testing potential algorithms to help... Read more

PerkinElmer Receives FDA Emergency Use Authorization for EUROIMMUN COVID-19 RT-PCR Test

Company’s latest FDA EUA solution broadens RT-PCR and serology offerings available in the U.S. WALTHAM, Mass. – June 15, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer Company, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for... Read more

FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients

FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific’s Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System CARLSBAD, Calif., June 15, 2020 /PRNewswire/ — The U.S. Food and Drug... Read more

GE Healthcare, Orange Healthcare and TheraPanacea collaborate with Assistance Publique-Hôpitaux de Paris and Société d'Imagerie Thoracique to create COVID-19 database and develop new AI-based tools

Paris, France –15 June 2020: GE Healthcare, Orange Healthcare and TheraPanacea plan a collaboration with Assistance Publique-Hôpitaux de Paris to create a database around chest imaging in patients suspected of being infected with SARS-Cov-2, the virus responsible for Covid-19. This collaboration supports the STOIC project (ThOracian Scanner for the dIagnosis of Coronavirus19 pneumonia – COVID-19)... Read more